Corinnova is a company headquartered in the United States.
Corinnova develops a minimally invasive, non-blood contacting cardiac assist device designed to treat acute heart failure by externally compressing the heart to increase cardiac output without direct blood contact.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.